A detailed history of Pinnacle Associates LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Pinnacle Associates LTD holds 33,030 shares of NVO stock, worth $3.36 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
33,030
Previous 33,722 2.05%
Holding current value
$3.36 Million
Previous $4.81 Million 18.3%
% of portfolio
0.06%
Previous 0.08%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$119.07 - $145.42 $82,396 - $100,630
-692 Reduced 2.05%
33,030 $3.93 Million
Q2 2024

Jul 30, 2024

SELL
$122.71 - $146.91 $13,988 - $16,747
-114 Reduced 0.34%
33,722 $4.81 Million
Q1 2024

Apr 26, 2024

BUY
$102.11 - $135.92 $82,300 - $109,551
806 Added 2.44%
33,836 $4.34 Million
Q4 2023

Jan 19, 2024

BUY
$87.78 - $105.45 $39,325 - $47,241
448 Added 1.37%
33,030 $3.42 Million
Q3 2023

Oct 23, 2023

BUY
$90.94 - $199.54 $947,685 - $2.08 Million
10,421 Added 47.02%
32,582 $2.96 Million
Q2 2023

Jul 26, 2023

SELL
$155.98 - $172.65 $65,511 - $72,513
-420 Reduced 1.86%
22,161 $3.59 Million
Q1 2023

May 04, 2023

BUY
$132.34 - $159.14 $24,350 - $29,281
184 Added 0.82%
22,581 $3.59 Million
Q4 2022

Jan 31, 2023

BUY
$102.55 - $135.33 $3,589 - $4,736
35 Added 0.16%
22,397 $3.03 Million
Q4 2022

Jan 25, 2023

BUY
$102.55 - $135.33 $83,578 - $110,293
815 Added 3.78%
22,362 $0
Q3 2022

Oct 31, 2022

SELL
$95.28 - $116.93 $86,704 - $106,406
-910 Reduced 4.05%
21,547 $2.15 Million
Q2 2022

Aug 02, 2022

SELL
$103.24 - $121.81 $183,767 - $216,821
-1,780 Reduced 7.34%
22,457 $2.5 Million
Q1 2022

May 05, 2022

SELL
$93.1 - $112.54 $127,546 - $154,179
-1,370 Reduced 5.35%
24,237 $2.69 Million
Q4 2021

Feb 02, 2022

BUY
$95.88 - $117.08 $213,812 - $261,088
2,230 Added 9.54%
25,607 $2.87 Million
Q3 2021

Oct 19, 2021

BUY
$84.42 - $106.62 $567,302 - $716,486
6,720 Added 40.34%
23,377 $2.24 Million
Q2 2021

Aug 02, 2021

SELL
$67.66 - $84.76 $21,312 - $26,699
-315 Reduced 1.86%
16,657 $1.4 Million
Q1 2021

May 12, 2021

SELL
$67.06 - $75.82 $147,196 - $166,424
-2,195 Reduced 11.45%
16,972 $1.14 Million
Q4 2020

Jan 26, 2021

SELL
$63.89 - $73.8 $150,460 - $173,799
-2,355 Reduced 10.94%
19,167 $1.34 Million
Q3 2020

Oct 23, 2020

SELL
$63.69 - $70.22 $6,369 - $7,022
-100 Reduced 0.46%
21,522 $1.49 Million
Q2 2020

Aug 14, 2020

BUY
$58.54 - $67.94 $13,464 - $15,626
230 Added 1.08%
21,622 $1.42 Million
Q1 2020

May 13, 2020

BUY
$49.46 - $64.78 $8,803 - $11,530
178 Added 0.84%
21,392 $1.29 Million
Q4 2019

Feb 03, 2020

SELL
$49.86 - $58.26 $49,860 - $58,260
-1,000 Reduced 4.5%
21,214 $1.23 Million
Q3 2019

Nov 08, 2019

SELL
$47.54 - $53.43 $17,066 - $19,181
-359 Reduced 1.59%
22,214 $1.15 Million
Q2 2019

Aug 05, 2019

SELL
$46.79 - $52.47 $42,578 - $47,747
-910 Reduced 3.88%
22,573 $1.15 Million
Q1 2019

May 10, 2019

SELL
$46.36 - $52.63 $60,824 - $69,050
-1,312 Reduced 5.29%
23,483 $1.23 Million
Q4 2018

Feb 05, 2019

SELL
$41.54 - $47.25 $1.6 Million - $1.82 Million
-38,470 Reduced 60.81%
24,795 $1.14 Million
Q3 2018

Nov 13, 2018

SELL
$46.76 - $51.24 $213,786 - $234,269
-4,572 Reduced 6.74%
63,265 $2.98 Million
Q2 2018

Aug 08, 2018

SELL
$44.29 - $50.42 $612,796 - $697,611
-13,836 Reduced 16.94%
67,837 $3.13 Million
Q1 2018

May 11, 2018

SELL
$48.49 - $58.14 $286,042 - $342,967
-5,899 Reduced 6.74%
81,673 $4.02 Million
Q4 2017

Feb 12, 2018

SELL
$47.53 - $53.73 $139,310 - $157,482
-2,931 Reduced 3.24%
87,572 $4.7 Million
Q3 2017

Nov 13, 2017

BUY
$41.15 - $49.22 $194,063 - $232,121
4,716 Added 5.5%
90,503 $4.36 Million
Q2 2017

Aug 09, 2017

BUY
N/A
85,787
85,787 $3.68 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Pinnacle Associates LTD Portfolio

Follow Pinnacle Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.